Bilateral Knees / Osteoarthritis / MFAT / VAS + KOOS JR

This Circle helps physicians capture and monetize real-world data from their everyday delivery of MFAT for Knee Osteoarthritis.

The Regenerative Medicine Market is valued at 32.5 USD Billion in 2023, and is estimated to grow to over 235.98 USD Billion by 2032. Osteoarthritis of the knee remains one of the most prevalent indications of adult men and women, and is treated area for MFAT therapy. Manufacturers will thus increasingly spend on obtaining and maintaining regulatory approvals for marketing those products for Knee Osteoarthritis. Increasingly, that spending will be focused on licensing real-world safety and efficacy data from their everyday customers.

This Circle helps physicians obtain and aggregate those high quality real-world data those companies are looking for. Participation is minimally burdensome, and members will receive recurring license fees once obtained and in accordance with their contribution of Knee Osteoarthritis cases, outcomes and other case data.